Publications

  1. Nowak RP, DeAngelo SL, Buckley D, He Z, Donovan KA, An J, Safaee N, Jedrychowski MP, Ponthier CM, Ishoey M, Zhang T, Mancias JD, Gray NS, Bradner JE, Fischer ES. Plasticity in binding confers selectivity in ligand-induced protein degradation. Nature Chemical Biology (Epub ahead of print). doi:10.1038/s41589-018-0055-y

  1. Olson CM, Jiang B, Erb MA, Liang Y, Doctor ZM, Zhang Z, Zhang T, Kwiatkowski N, Boukhali M, Green JL, Haas W, Nomanbhoy T, Fischer ES, Young RA, Bradner JE, Winter GE, Gray NS. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nature chemical biology. 2017 (Epub ahead of print)

  2. Huang HT, Dobrovolsky D, Paulk J, Yang G, Weisberg EL, Doctor ZM, Buckley DL, Cho JH, Ko E, Jang J, Shi K, Choi HG, Griffin JD, Li Y, Treon SP, Fischer ES, Bradner JE, Tan L, Gray NS. A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader. Cell chemical biology. 2017 (Epub ahead of print)

  3. Zeng M, Lu J, Li L, Feru F, Quan C, Gero TW, Ficarro SB, Xiong Y, Ambrogio C, Paranal RM, Catalano M, Shao J, Wong KK, Marto JA, Fischer ES, Jänne PA, Scott DA, Westover KD, Gray NS. Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C. Cell chemical biology. 2017; 24(8):1005-1016.e3.

  4. An J, Ponthier CM, Sack R, Seebacher J, Stadler MB, Donovan KA, Fischer ES. pSILAC mass spectrometry reveals ZFP91 as IMiD dependent substrate of the CRL4CRBN ubiquitin ligase. Nature Communications, DOI:10.1038/ncomms15398.

  5. Cavadini S, Fischer ES, Bunker RD, Potenza A, Lingaraju GM, Goldie KN, Mohamed WI, Faty M, Petzold G, Beckwith RE, Tichkule RB, Hassiepen U, Abdulrahman W, Pantelic RS, Matsumoto S, Sugasawa K, Stahlberg H, Thomä NH. Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosome. Nature 2016 Mar 31;531(7596):598-603.

  6. Fischer, E.S.‡, Park, E., Eck, M.J.‡, Thomä, N.H‡. SPLINTS: small-molecule protein ligand interface stabilizers. Curr. Opin. Struct. Biol. 2016; 37:115-122

  7. Petzold, G., Fischer, E.S., Thomä, N.H. Structural basis of lenalidomide-induced CK1a degradation by the CRL4(CRBN) ubiquitin ligase. Nature 2016 [Epub ahead of print]

  8. Matsumoto, S., Fischer, E.S., Yasuda, T., Dohmae, N., Iwai, S. Mori, T., Nishi, R., Yoshino, K., Sakai, W., Hanaoka, F., Thoma, N.H., Sugasawa, K. Functional regulation of the DNA damage-recognition factor DDB2 by ubiquitination and interaction with xeroderma pigmentosum group C protein. Nucleic Acids Research 2015 Feb 18; 43(3): 1700-13. PMCID: PMC4330392.

  9. Lingaraju, G.M.*, Bunker, R.D.*, Cavadini, S., Hess, D., Hassiepen, U., Renatus, M., Fischer, E.S., Thomä, N.H. Crystal structure of the human COP9 Signalosome. Nature 2014; 512(7513): 161-165.

  10. Fischer, E.S., Böhm, K., Lydeard, J.R., Yang, H., Stadler, M.B., Cavadini, S., Nagel, J., Acker, V., Tichkule, R., Forrester, W.C., Schirle, M., Hassiepen, U., Ottl, J., Hild, M., Beckwidth, R.E.J., Harper, J.W., Jenkins, J.L., Thomä, N.H. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.  Nature 2014; 512(7512): 49-53. PMCID: PMC4423819.

  11. Fischer, E.S.*, Scrima, A.*, Boehm, K., Matsumoto, S., Lingaraju, G.M., Faty, M., Yasuda, T., Cavadini, S., Wakasugi, M., Hanaoka, F., Iwai, S., Gut, H., Sugasawa, K., Thomä, N.H. The molecular basis of CRL4DDB2/CSA Ubiquitin Ligase Architecture, Targeting and Activation. Cell 2011; 147(5): 1024-1039. 

  12. Scrima, A., Fischer, E.S., Lingaraju, G.M., Böhm, K., Cavadini, S., Thomä, N.H. Detecting UV-lesions in the genome: The modular CRL4 ubiquitin ligase does it best!. FEBS Lett. 2011; 585(18): 2818-25.

* equal contribution
‡ shared corresponding authors
Click HERE for my PubMed